Sign in
4

Changes in Ownership

Tyra Biosciences, Inc. Filed Acc 0001415889-25-015139

Options or other derivatives

  • Director acquired 22,200 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
RA CAPITAL MANAGEMENT, L.P. Director 2025-05-29 Grant or award · Stock Option (Right to Buy) +22,200 22,200 I
Loading xslF345X05/form4-06022025_080640.xml…